Hypertension

Certain lots of the therapy, distributed under the Actavis label in the US, have been detected to have trace amounts of probably human carcinogen NDMA.

The Cleveland Clinic’s pioneer of minority programs plans to end health disparity.

A recent case review feature in Hypertension got this author thinking first and foremost about medication adherence. Your thoughts?

AF is associated with major disease burden, predominately in the form of cardiovascular comorbidities. As a direct oral anti-coagulant, rivaroxaban has been a proven inhibitor of ischemic stroke risks in patients with AF.

Trials of valbenazine for TD do not find that the treatment adds to cardiovascular disease risks associated with schizophrenia or the cardiovascular complications of antipsychotics.

How some of the most recent trial analysis narrows the clinical scope of GLP-1 and SGLT-2 targeting therapies.

H-CKD may soon be more than a "phenotype of convenience with little clinical utility." How will precision medicine hone diagnosis and treatment?

Facing a major CVD prevalence in 30 million-plus patients with type 2 diabetes, the national agencies are planning a collaborative initiative that will last years.

The American Heart Association chief medical officer for prevention discussed the new ADA partnership and the new emphasis on comorbidity care.

Those with hypertension had roughly 2.5 times more inpatient costs, almost twice the outpatient cost, and roughly triple the prescription medication cost annually.

Treated with Medtronic’s Symplicity Spyral renal denervation system, those patients experienced no major adverse safety events at 6 months.

The study estimated that full achievement of the 2017 hypertension guidelines would prevent 610,000 major cardiovascular events and 334,000 deaths in the US annually.

The filing is supported by data from MERIT-1 which showed great improvements in pulmonary vascular resistance and 6-minute walk distance versus ongoing background therapy.

Mobile apps have a high potential for improving treatment adherence, but rigorous testing is still needed to determine efficacy.

While pre-pregnancy blood pressure can impact pregnancy outcomes, targeted lifestyle interventions could be utilized to favorably impact reproductive health.

The device is approved for commercial use in more than 50 countries but is limited to investigational use in the United States and Japan.

Researchers note that efforts are needed to align clinical practice with clinical guidelines.

Weight from age 25 onwards has been linked to the risk of more or less heart damage, as measured by levels of the protein troponin, underscoring the importance of long-term weight control.

More potent than hydrochlorothiazide to treat hypertension, this non-thiazide diuretic deserves a closer look.

Chlorthalidone is one of the "Rodney Dangerfield" diuretics in the treatment of hypertension. That needs to change.

This 83-year-old man is treated only for hypertension and says he "feels like Tarzan." The routine ECG says otherwise.

Click through this short case study for an illustration of the key principles put forth in the revised ACC/AHA guidelines on hypertension diagnosis and management.